Picture offshore wind farm

Open Access: World leading research into plasma physics...

Strathprints makes available scholarly Open Access content by researchers in the Department of Physics, including those researching plasma physics.

Plasma physics explores the '4th' state of matter known as 'plasma'. Profound new insights are being made by Strathclyde researchers in their attempts to better understand plasma, its behaviour and applications. Areas of focus include plasma wave propagation, non-linear wave interactions in the ionosphere, magnetospheric cyclotron instabilities, the parametric instabilities in plasmas, and much more.

Based on the REF 2014 GPA Scores, Times Higher Education ranked Strathclyde as number one in the UK for physics research.

Explore Open Access plasma physics research and of the Department of Physics more generally. Or explore all of Strathclyde's Open Access research...

The breath test - A call for more regional use

Heaney, A. and Kalin, R.M. and Collins, J.S.A. and Watson, R.G.P. and McFarland, R.J. (1997) The breath test - A call for more regional use. European Journal of Gastroenterology and Hepatology, 9 (7). pp. 693-696.

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Objective: Although the C-13-urea breath test is commonly used for detection of Helicobacter pylori infection and eradication, access to commercial testing centres for analysis may at times limit its use. We have addressed this issue by establishing a regional-based means of analysis as a Hospital-University collaboration. Design/methods: A blind comparison was undertaken of C-13-urea breath test results performed 'in house' by the stable isotope laboratory in Queen's University Belfast and a commercially available C-13-urea breath test. Results: The H. pylori status of the patients (n = 110) agreed for all patients (kappa score = 1). The excess values showed good agreement. The cost of the 'in house' breath test was less than 20 pounds compared with 32.90 pounds for the commercial breath test. Conclusion: Regional access to the C-13-urea breath test could decrease costs, increase availability of testing, improve local health services and economy and increase collaborative research opportunities.